Leah Anderson, PhD, is a Senior Regulatory Affairs Associate at Kenvue. In her role she provides regulatory guidance to local and global business partners, enabling advancement of business growth obje
Daniella Espinoza, MAT is a Medical Writing Scientist. She is responsible for delivery of clinical documents with input to support the development, regulatory, and maintenance of healthcare products.
Valery Hernández-Rodríguez is an Associate FUEL Rotational Program at Amgen
Chiamaka (Chi-Chi) Ukachukwu, Ph.D is an ‘Advisor’ and she is a full-time employee in the Medicines Innovation Hub (MIH) Leadership Development Program (LDP).
Tamisha Vaughan, PhD, manages programs Arrowhead has partnered with or licensed ranging from Discovery to Ph3 stages.
Ariana D. Cherry PhD, is a part of Talent Development Academy (TDA) Leadership Development Rotational Program (LDP). She was hired on as a full-time employee with the opportunity to complete three, 8-
Angel Santiago-Lopez, PhD is a Principal Scientist in late-stage Drug Substance Process Development at Amgen. He leads a team of cell culture and protein purification scientists.
Mario Guitierrez, PhD, is a Preclinical Senior Scientist in Oral Formulations at Merck. As a formulation scientist, he works to optimize drug product formulations for clinical supply.
Kelsey Johnson, PhD, is a Preclinical Toxicologist. She coordinates toxicology studies focused on assessing potential adverse effects of novel pharmaceutical compounds.
LaKeisha Batts PhD, provides regulatory oversight for the development and approval of clinical trial applications (Phases I-V) in ex-US countries and have global responsibility for all regulatory acti
System Verification Engineer: create, validate, and execute test methods to verify capital system requirements.
I work as a senior scientist for AstraZeneca were I am part of a team that evaluates oncology drug
targets and novel therapies.
She leads early career development programs and strategic operations for their discovery organization to ensure that their business is running efficiently
I practice evidence-based medicine by integrating pharmacology, exposure, epidemiology, and clinical data to drive drug development decisions with a patient-centric focus.
Dr. Nancy Guillen was recently appointed as an Associate Director in Upstream Development at (J&J) Innovative Medicines
David Swain works in works in the Advanced Technology Business unit at Edwards Lifesciences